Recombinant multi-species MAPK6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPK6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the Ser/Thr protein kinase family, and is most closely related to mitogen-activated protein kinases (MAP kinases). MAP kinases also known as extracellular signal-regulated kinases (ERKs), are activated through protein phosphorylation cascades and act as integration points for multiple biochemical signals. This kinase is localized in the nucleus, and has been reported to be activated in fibroblasts upon treatment with serum or phorbol esters. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2610021I23Rik,D130053K17Rik,ERK3,Erk3,Extracellular signal-regulated kinase 3 (ERK-3),HsT17250,MAP kinase 6,MAP kinase isoform p97 (p97-MAPK),MAPK 6,MAPK6,Mapk4,Mapk6,Mapk63,Mitogen-activated protein kinase 6,PRKM6,Prkm4,Prkm6,p97MAPK
Go
to MAPK6 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP10368-Ag-1/ GM-Tg-hg-IP10368-Ag-2 | Human MAPK6 protein | Human |
| GM-Tg-rg-IP10368-Ag-1/ GM-Tg-rg-IP10368-Ag-2 | Rat MAPK6 protein | Rat |
| GM-Tg-mg-IP10368-Ag-1/ GM-Tg-mg-IP10368-Ag-2 | Mouse MAPK6 protein | Mouse |
| GM-Tg-cynog-IP10368-Ag-1/ GM-Tg-cynog-IP10368-Ag-2 | Cynomolgus/Rhesus macaque MAPK6 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP10368-Ag-1/ GM-Tg-felg-IP10368-Ag-2 | Feline MAPK6 protein | Feline |
| GM-Tg-cang-IP10368-Ag-1/ GM-Tg-cang-IP10368-Ag-2 | Canine MAPK6 protein | Canine |
| GM-Tg-bovg-IP10368-Ag-1/ GM-Tg-bovg-IP10368-Ag-2 | Bovine MAPK6 protein | Bovine |
| GM-Tg-equg-IP10368-Ag-1/ GM-Tg-equg-IP10368-Ag-2 | Equine MAPK6 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP10368-Ag-1/ GM-Tg-hg-IP10368-Ag-2;
GM-Tg-rg-IP10368-Ag-1/ GM-Tg-rg-IP10368-Ag-2;
GM-Tg-mg-IP10368-Ag-1/ GM-Tg-mg-IP10368-Ag-2; GM-Tg-cynog-IP10368-Ag-1/ GM-Tg-cynog-IP10368-Ag-2; GM-Tg-felg-IP10368-Ag-1/ GM-Tg-felg-IP10368-Ag-2; GM-Tg-cang-IP10368-Ag-1/ GM-Tg-cang-IP10368-Ag-2; GM-Tg-bovg-IP10368-Ag-1/ GM-Tg-bovg-IP10368-Ag-2; GM-Tg-equg-IP10368-Ag-1/ GM-Tg-equg-IP10368-Ag-2 |
| Products Name | MAPK6 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MAPK6 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPK6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.